van Greevenbroek, Anke Wessel Cardiovascular Diabetology.2025;[Epub] CrossRef Glucagon-like Peptide-1 Receptor Agonists in Heart Failure: Mechanisms, Evidence and Identifying Optimal Candidates Magdy Abdelhamid, Mostafa M Abdrabou, Emanuel Faris, Sameh El Kafas, Mohamed Hosny, Ahmed Hassan Cardiac Failure Review.2025;[Epub] CrossRef Liraglutide does not increase heart rate of diabetic patients during acute myocardial infarction Qianyi Li, Chunxuan Wu, Shiqun Sun, Lingchao Yang, Yanyan Li, Yixin Niu, Li Zhang, Wei Li, Ying Yu Journal of Diabetes.2024;[Epub] CrossRef A randomized, doubleblind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARDJPN) Tomoaki Morioka, Masakazu Takeuchi, Akichika Ozeki, Masanori Emoto Diabetes, Obesity and Metabolism.2024
Compounding pharmacies do not add B12 randomly
Not adjusting when switching pharmacies Switching compounding pharmacies without recalculating your dose is dangerous
How might we step forward
IGF-1 LR3 is only legal for use in laboratories but it has found its way to the bodybuilding market
The medications are expensive, though some insurance does cover them for appropriate indications
